SHARON HOCHHAUSER: Open Payments
NPI 1881185973 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 52 payments from 13 companies in 2025. Trend: 2023 $865 · 2024 $1,122 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $255 |
| ABBVIE INC. | 11 | $194 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Organon LLC | 5 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $59 |
| Janssen Biotech, Inc. | 2 | $47 |
| UCB, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
Products named: OPZELURA, RINVOQ, SKYRIZI, VTAMA, ILUMYA, COSENTYX, TREMFYA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
